Showing 331-340 of 2882 results for "".
Amyotrophic Lateral Sclerosis
https://practicalneurology.com/diseases-diagnoses/neuromuscular/amyotrophic-lateral-sclerosis-1/31691/There are both disease-modifying and symptom-reducing treatments available and emerging treatment possibilities.Brain Imaging in Differential Diagnosis of Dementia
https://practicalneurology.com/diseases-diagnoses/imaging-testing/brain-imaging-in-differential-diagnosis-of-dementia/31533/Imaging biomarkers hold the promise of earlier diagnosis that may lead to more effective treatment.Expert Opinion: Emerging Strategies for Rehabilitation of the Stroke Patient
https://practicalneurology.com/diseases-diagnoses/stroke/1109_07-php/30876/In the past few decades, new understanding about the plasticity of nervous system organization coupled with innovative techniques for physical therapy have provided new options for post-stroke rehabilitation.Case Report: A Woman with Tinnitus and Tongue Atrophy
https://practicalneurology.com/diseases-diagnoses/imaging-testing/case-report-a-woman-with-tinnitus-and-tongue-atrophy/30137/Glomus tumors, the great masquerader, have variable presentation and multiple treatment options.Autologous Umbilical Cord Blood Treatment for Autism: Rationale and Potential Goals of Treatment
https://practicalneurology.com/columns/practice-management/autologous-umbilical-cord-blood-treatment-for-autism-rationale-and-potential-goals-of-treatment/30725/Could autologous umbilical cord blood (AUCB) offer stem cells that could alter functionality of aberrant immune or nervous system cells affected by some environmental factor in patients with negative genetic screening for autism?Disclosing Risk Factors to Individuals Without Cognitive Impairment
https://practicalneurology.com/diseases-diagnoses/alzheimer-disease-dementias/disclosing-risk-factors-to-individuals-withoutcognitive-impairment/31535/Negative consequences of risk factor disclosure are likely to be most severe among people who are inadequately prepared to receive the information.Multiple Sclerosis and COVID-19
https://practicalneurology.com/diseases-diagnoses/ms-immune-disorders/multiple-sclerosis-and-covid-19/31725/Understanding the immune system, drug proposed mechanisms of action, and considerations for care during COVID-19.Fringe Benefit Plans: Valuable Planning Tools You Haven't Heard Of
https://practicalneurology.com/columns/practice-management/tax-planning/30683/Fringe benefit plans lack many of the restrictions of qualified plans, and, therefore, are relatively inexpensive to implement.Muscle Cramps
https://practicalneurology.com/diseases-diagnoses/neuromuscular/muscle-cramps/31559/Reliable and validated outcome measures and new treatments are needed.Telestroke & Telecritical Care
https://practicalneurology.com/diseases-diagnoses/imaging-testing/telestroke-telecritical-care/31745/Recent advances in telestroke and telecritical care have improved outcomes, although COVID-19 will have long-lasting effects on these services.